ArticleClinical ophthalmology (Auckland, N.Z.)2025
Visual and Refractive Outcomes of a New Monofocal, Non-Constant Aberration-Correcting Aspheric Intraocular Lens.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Short-Term Visual and Optical Performance of the ZEISS CT LUCIA 621P Intraocular Lens Across Different Power Ranges.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess early visual and refractive outcomes of the CT Lucia 621PY intraocular lens (IOL). Methods: Retrospective analysis was performed for 47 consecutive eyes from 33 patients following routine phacoemulsification and implantation of CT Lucia 621PY monofocal IOLs for the treatment of cataract. Postoperative analysis was performed 6-weeks following surgery. Uncorrected distance visual acuity (UDVA), best-corrected distance visual acuity (BCVA) and manifest refraction were measured for all patients. Uncorrected mesopic contrast sensitivity (CS) was measured for a subset of 22 of the 47 eyes, and modulated transfer function (MTF) and angle alpha and angle kappa were measured for a separate subset of 19 eyes. Results: Mean spherical equivalent (SE) was -0.04±0.38 D, with 83% of eyes achieving within ±0.5 D of the refractive target. Mean UDVA was 0.05±0.1 LogMAR at 6 weeks postoperative, with 98% of eyes achieving 0.2 LogMAR or better. Mean BCVA was -0.02±0.06 LogMAR, with 87% of eyes achieving 0.00 LogMAR or better. Mean mesopic monocular CS was 1.4±0.26 sec arc, and 50% contrast was maintained at a spatial frequency of approximately 13 cycles per degree. There was no significant correlation between MTF and angle alpha or angle kappa. Conclusion: The CT Lucia 621PY offers good visual and refractive outcomes. While there was no significant correlation between angle alpha or angle kappa and visual quality, further investigation is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.